What has NICE said?

What has NICE said?

Pixantrone monotherapy is recommended as a possible treatment for adults with multiply relapsed or refractory aggressive non-Hodgkin's B‑cell lymphoma if:

  • they have previously been treated with rituximab and

  • they are having third- or fourth-line treatment.

What does this mean for me?

If you have non-Hodgkin's B-cell lymphoma, and your doctor thinks that pixantrone is the right treatment, you should be able to have it on the NHS.

Pixantrone should be available on the NHS within 3 months of the guidance being issued. If you are not eligible for treatment on the NHS as described above, you should be able to continue having pixantrone until you and your doctor decide it is the right time to stop.

  • Information Standard